| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled purinergic nucleotide receptor activity | 4.34e-04 | 13 | 48 | 2 | GO:0045028 | |
| GeneOntologyMolecularFunction | glucosidase activity | 5.82e-04 | 15 | 48 | 2 | GO:0015926 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | TAAR3P FCRL5 GPR174 PKD1L3 PTPRG P2RY2 P2RY11 RGR SIGLEC8 SORL1 | 1.21e-03 | 1353 | 48 | 10 | GO:0004888 |
| GeneOntologyMolecularFunction | nucleotide receptor activity | 1.27e-03 | 22 | 48 | 2 | GO:0016502 | |
| GeneOntologyMolecularFunction | purinergic nucleotide receptor activity | 1.27e-03 | 22 | 48 | 2 | GO:0001614 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 1.95e-03 | 103 | 48 | 3 | GO:0004553 | |
| GeneOntologyMolecularFunction | complement binding | 2.68e-03 | 32 | 48 | 2 | GO:0001848 | |
| GeneOntologyCellularComponent | cell surface | HYAL4 SLC6A3 CFH LRP4 FCRL1 FCRL5 BSN PKD1L3 LCT SIGLEC8 SORL1 | 3.34e-05 | 1111 | 48 | 11 | GO:0009986 |
| GeneOntologyCellularComponent | nuclear envelope lumen | 4.62e-04 | 14 | 48 | 2 | GO:0005641 | |
| Domain | EGF | 2.94e-05 | 235 | 48 | 6 | SM00181 | |
| Domain | EGF_2 | 5.74e-05 | 265 | 48 | 6 | PS01186 | |
| Domain | LDLR_class-A_CS | 1.47e-04 | 40 | 48 | 3 | IPR023415 | |
| Domain | Ldl_recept_a | 2.10e-04 | 45 | 48 | 3 | PF00057 | |
| Domain | - | 2.24e-04 | 46 | 48 | 3 | 4.10.400.10 | |
| Domain | LDLRA_1 | 2.54e-04 | 48 | 48 | 3 | PS01209 | |
| Domain | LDLRA_2 | 2.70e-04 | 49 | 48 | 3 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 2.70e-04 | 49 | 48 | 3 | IPR002172 | |
| Domain | LDLa | 2.70e-04 | 49 | 48 | 3 | SM00192 | |
| Domain | EGF | 3.05e-04 | 126 | 48 | 4 | PF00008 | |
| Domain | EGF_3 | 3.33e-04 | 235 | 48 | 5 | PS50026 | |
| Domain | ABC_A | 4.20e-04 | 12 | 48 | 2 | IPR026082 | |
| Domain | EGF-like_dom | 4.34e-04 | 249 | 48 | 5 | IPR000742 | |
| Domain | EGF_1 | 4.84e-04 | 255 | 48 | 5 | PS00022 | |
| Domain | EGF-like_CS | 5.38e-04 | 261 | 48 | 5 | IPR013032 | |
| Domain | Ldl_recept_b | 5.77e-04 | 14 | 48 | 2 | PF00058 | |
| Domain | LDLRB | 5.77e-04 | 14 | 48 | 2 | PS51120 | |
| Domain | LY | 6.65e-04 | 15 | 48 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 6.65e-04 | 15 | 48 | 2 | IPR000033 | |
| Domain | Ig_2 | 8.73e-04 | 73 | 48 | 3 | PF13895 | |
| Domain | - | 1.43e-03 | 663 | 48 | 7 | 2.60.40.10 | |
| Domain | Ig-like_fold | 2.04e-03 | 706 | 48 | 7 | IPR013783 | |
| Domain | ConA-like_dom | 2.39e-03 | 219 | 48 | 4 | IPR013320 | |
| Domain | IGc2 | 3.08e-03 | 235 | 48 | 4 | SM00408 | |
| Domain | Ig_sub2 | 3.08e-03 | 235 | 48 | 4 | IPR003598 | |
| Domain | MAGE | 3.44e-03 | 34 | 48 | 2 | SM01373 | |
| Domain | MAGE | 3.85e-03 | 36 | 48 | 2 | PS50838 | |
| Domain | MAGE | 3.85e-03 | 36 | 48 | 2 | PF01454 | |
| Domain | MHD_dom | 3.85e-03 | 36 | 48 | 2 | IPR002190 | |
| Domain | LAM_G_DOMAIN | 4.29e-03 | 38 | 48 | 2 | PS50025 | |
| Domain | - | 4.51e-03 | 39 | 48 | 2 | 2.120.10.30 | |
| Domain | Laminin_G_2 | 4.74e-03 | 40 | 48 | 2 | PF02210 | |
| Domain | LamG | 5.71e-03 | 44 | 48 | 2 | SM00282 | |
| Domain | 6-blade_b-propeller_TolB-like | 6.23e-03 | 46 | 48 | 2 | IPR011042 | |
| Domain | ABC_tran | 6.77e-03 | 48 | 48 | 2 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 6.77e-03 | 48 | 48 | 2 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 7.04e-03 | 49 | 48 | 2 | PS00211 | |
| Domain | ABC_transporter-like | 7.32e-03 | 50 | 48 | 2 | IPR003439 | |
| Domain | Sushi | 7.90e-03 | 52 | 48 | 2 | PF00084 | |
| Domain | Glycoside_hydrolase_SF | 8.20e-03 | 53 | 48 | 2 | IPR017853 | |
| Domain | CCP | 8.50e-03 | 54 | 48 | 2 | SM00032 | |
| Domain | SUSHI | 9.12e-03 | 56 | 48 | 2 | PS50923 | |
| Domain | VWA | 9.12e-03 | 56 | 48 | 2 | PF00092 | |
| Domain | Sushi_SCR_CCP_dom | 9.43e-03 | 57 | 48 | 2 | IPR000436 | |
| Domain | Laminin_G | 9.76e-03 | 58 | 48 | 2 | IPR001791 | |
| Pubmed | 8.88e-07 | 14 | 48 | 3 | 19015224 | ||
| Pubmed | Complement factor H is expressed in adipose tissue in association with insulin resistance. | 1.87e-06 | 2 | 48 | 2 | 19833879 | |
| Pubmed | Novel interaction at the Cdx-2 binding sites of the lactase-phlorizin hydrolase promoter. | 1.87e-06 | 2 | 48 | 2 | 12459179 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 27241480 | ||
| Pubmed | Association of CFH and CFB gene polymorphisms with retinopathy in type 2 diabetic patients. | 1.87e-06 | 2 | 48 | 2 | 23864767 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 12091909 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 17420242 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 23112567 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 19899988 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 34233521 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 19825847 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 20007824 | ||
| Pubmed | ATM gene variants in patients with idiopathic perifoveal telangiectasia. | 5.59e-06 | 3 | 48 | 2 | 18502988 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 33410734 | ||
| Pubmed | Complement factor H-deficient mice develop spontaneous hepatic tumors. | 5.59e-06 | 3 | 48 | 2 | 32369457 | |
| Pubmed | Variation in complement factor 3 is associated with risk of age-related macular degeneration. | 5.59e-06 | 3 | 48 | 2 | 17767156 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 19187590 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 21555552 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 33536243 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 21163532 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 10677375 | ||
| Pubmed | Serum Levels of Complement Factors C1q, Bb, and H in Normal Pregnancy and Severe Pre-Eclampsia. | 5.59e-06 | 3 | 48 | 2 | 31541546 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 23356914 | ||
| Pubmed | Differential B cell expression of mouse Fc receptor homologs. | 5.59e-06 | 3 | 48 | 2 | 15302849 | |
| Pubmed | 6.53e-06 | 87 | 48 | 4 | 20801516 | ||
| Pubmed | 9.88e-06 | 359 | 48 | 6 | 35559673 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 23233260 | ||
| Pubmed | C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes. | 1.12e-05 | 4 | 48 | 2 | 18493315 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 19399715 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 19001225 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 20106822 | ||
| Pubmed | A2E accumulation influences retinal microglial activation and complement regulation. | 1.12e-05 | 4 | 48 | 2 | 22819137 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 30179527 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 18802695 | ||
| Pubmed | C3 R102G polymorphism increases risk of age-related macular degeneration. | 1.12e-05 | 4 | 48 | 2 | 18325906 | |
| Pubmed | Complement C3b interactions studied with surface plasmon resonance technique. | 1.12e-05 | 4 | 48 | 2 | 11367533 | |
| Pubmed | The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype. | 1.12e-05 | 4 | 48 | 2 | 21816153 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 25646087 | ||
| Pubmed | Complement factor H deficiency results in decreased neuroretinal expression of Cd59a in aged mice. | 1.12e-05 | 4 | 48 | 2 | 22918646 | |
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 18704934 | ||
| Pubmed | Species-specific evolution of the FcR family in endothermic vertebrates. | 1.86e-05 | 5 | 48 | 2 | 17356879 | |
| Pubmed | Regulation of C3 Activation by the Alternative Complement Pathway in the Mouse Retina. | 1.86e-05 | 5 | 48 | 2 | 27564415 | |
| Pubmed | Identification of a family of Fc receptor homologs with preferential B cell expression. | 1.86e-05 | 5 | 48 | 2 | 11493702 | |
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 20157618 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 20378180 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 24453474 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 16849395 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 11690642 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 19169232 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 18515590 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 19047013 | ||
| Pubmed | IRTAs: a new family of immunoglobulinlike receptors differentially expressed in B cells. | 1.86e-05 | 5 | 48 | 2 | 11929751 | |
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 18936151 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 20675597 | ||
| Pubmed | Genetic association with response to intravitreal ranibizumab in patients with neovascular AMD. | 1.86e-05 | 5 | 48 | 2 | 21282580 | |
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 20523265 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 17272516 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 19117936 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 12111378 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 16622424 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 16849499 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 24557084 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 23235567 | ||
| Pubmed | 2.80e-05 | 257 | 48 | 5 | 16335952 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 3.38e-05 | 1201 | 48 | 9 | 35696571 | |
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 20513133 | ||
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 20861866 | ||
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 19259132 | ||
| Pubmed | 5.19e-05 | 8 | 48 | 2 | 22694956 | ||
| Pubmed | Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept. | 5.19e-05 | 8 | 48 | 2 | 19567891 | |
| Pubmed | Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration. | 5.19e-05 | 8 | 48 | 2 | 20888482 | |
| Pubmed | 5.19e-05 | 8 | 48 | 2 | 20301598 | ||
| Pubmed | 6.15e-05 | 55 | 48 | 3 | 10926756 | ||
| Pubmed | Laminin γ1 C-terminal Glu to Gln mutation induces early postimplantation lethality. | 6.67e-05 | 9 | 48 | 2 | 30456378 | |
| Pubmed | FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation. | 6.67e-05 | 9 | 48 | 2 | 28533443 | |
| Pubmed | 8.33e-05 | 10 | 48 | 2 | 22705344 | ||
| Pubmed | 1.02e-04 | 11 | 48 | 2 | 20301541 | ||
| Pubmed | Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis. | 1.02e-04 | 11 | 48 | 2 | 23204401 | |
| Pubmed | The first avian Ig-like Fc receptor family member combines features of mammalian FcR and FCRL. | 1.22e-04 | 12 | 48 | 2 | 17273841 | |
| Pubmed | Cell surface heparan sulfate chains regulate local reception of FGF signaling in the mouse embryo. | 1.44e-04 | 13 | 48 | 2 | 21839920 | |
| Pubmed | Blimp1 regulates the transition of neonatal to adult intestinal epithelium. | 1.44e-04 | 13 | 48 | 2 | 21878906 | |
| Pubmed | 1.68e-04 | 14 | 48 | 2 | 21665990 | ||
| Pubmed | 1.68e-04 | 14 | 48 | 2 | 23577725 | ||
| Pubmed | 1.68e-04 | 14 | 48 | 2 | 23620142 | ||
| Pubmed | 1.94e-04 | 15 | 48 | 2 | 20385826 | ||
| Pubmed | 2.21e-04 | 16 | 48 | 2 | 17137217 | ||
| Pubmed | Genetic predictors of fibrin D-dimer levels in healthy adults. | 2.21e-04 | 16 | 48 | 2 | 21502573 | |
| Pubmed | No replication of genetic association between candidate polymorphisms and Alzheimer's disease. | 2.21e-04 | 16 | 48 | 2 | 19889475 | |
| Pubmed | 2.21e-04 | 16 | 48 | 2 | 16880404 | ||
| Pubmed | 2.50e-04 | 17 | 48 | 2 | 20385819 | ||
| Pubmed | An overview of the MAGE gene family with the identification of all human members of the family. | 2.81e-04 | 18 | 48 | 2 | 11454705 | |
| Pubmed | Development of a diagnostic genetic test for simplex and autosomal recessive retinitis pigmentosa. | 2.81e-04 | 18 | 48 | 2 | 20591486 | |
| Pubmed | 3.14e-04 | 19 | 48 | 2 | 31345929 | ||
| Pubmed | 3.49e-04 | 20 | 48 | 2 | 20637749 | ||
| Pubmed | 4.23e-04 | 22 | 48 | 2 | 18448648 | ||
| Pubmed | A mouse knockout library for secreted and transmembrane proteins. | 4.25e-04 | 460 | 48 | 5 | 20562862 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | 4.61e-04 | 1016 | 48 | 7 | 19056867 | |
| Pubmed | 5.48e-04 | 25 | 48 | 2 | 30718509 | ||
| Pubmed | Genetic risk profiling and prediction of disease course in Crohn's disease patients. | 6.89e-04 | 28 | 48 | 2 | 19422935 | |
| Pubmed | Seven new loci associated with age-related macular degeneration. | 7.39e-04 | 29 | 48 | 2 | 23455636 | |
| GeneFamily | Purinergic receptors P2Y | 1.72e-04 | 10 | 36 | 2 | 213 | |
| GeneFamily | ATP binding cassette subfamily A | 3.46e-04 | 14 | 36 | 2 | 805 | |
| GeneFamily | Complement system|Sushi domain containing | 2.33e-03 | 36 | 36 | 2 | 492 | |
| GeneFamily | MAGE family | 2.87e-03 | 40 | 36 | 2 | 1136 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 5.74e-03 | 57 | 36 | 2 | 1179 | |
| GeneFamily | Immunoglobulin like domain containing | 6.60e-03 | 193 | 36 | 3 | 594 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 3.86e-05 | 445 | 45 | 7 | GSM777043_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 5.28e-05 | 97 | 45 | 4 | GSM777043_100 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#3_top-relative-expression-ranked_200 | 1.22e-04 | 8 | 45 | 2 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k3_200 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.03e-06 | 193 | 48 | 5 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.03e-06 | 193 | 48 | 5 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.03e-06 | 193 | 48 | 5 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.14e-06 | 195 | 48 | 5 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.42e-06 | 200 | 48 | 5 | 8a4c210a3130f7baedf15ecbc0f4903b97da0352 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-red_blood_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 56 | 48 | 3 | 55337ff90621e1fea4d747ae2559c0fa61b38dce | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 3.29e-05 | 169 | 48 | 4 | 84b898a9fd8ced67c6a501d5cef6416f519902c4 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 3.29e-05 | 169 | 48 | 4 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.29e-05 | 169 | 48 | 4 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.29e-05 | 169 | 48 | 4 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.68e-05 | 174 | 48 | 4 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.11e-05 | 179 | 48 | 4 | dcd0a83f0592ae27f814d064b4791f84c3c86e64 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pou6f2-Inhibitory_Neuron.Gad1Gad2.Pou6f2-Pax6_(Zona_incerta_(ZI))|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.12e-05 | 62 | 48 | 3 | 02f0398e18bd61fbfa03bce71ae77e106181abee | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pou6f2-Inhibitory_Neuron.Gad1Gad2.Pou6f2-Pax6_(Zona_incerta_(ZI))-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.12e-05 | 62 | 48 | 3 | 8fdbced7a2baa1bfb5b1e204128234424a872fe6 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pou6f2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.12e-05 | 62 | 48 | 3 | ff68e007b8b2af4c7fb09139aed92e86907a05da | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-05 | 180 | 48 | 4 | ea7a1ccf0dd3bb5af5df87501f873e7339a824b3 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.29e-05 | 181 | 48 | 4 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.39e-05 | 182 | 48 | 4 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.67e-05 | 185 | 48 | 4 | e1fbec55b71f604189eb2431768fadbaa0453a83 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.67e-05 | 185 | 48 | 4 | 9d933cd5ebc8368fd37aa83113d2dfa6938ff72d | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 4.67e-05 | 185 | 48 | 4 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-B_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-05 | 188 | 48 | 4 | a7158b5c94e6b356877f016e52f2c24a3f5d24d2 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.08e-05 | 189 | 48 | 4 | 40cbd679dc0548bf5207e1b033c0597886ad6fe1 | |
| ToppCell | droplet-Lung-immune-endo-depleted|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-05 | 189 | 48 | 4 | c3fb363bb0156ffb3367c200f548faebda64ab4a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-05 | 189 | 48 | 4 | 2a2953f6b1b7d070d739dcaf7285fce6e097d9e4 | |
| ToppCell | droplet-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.08e-05 | 189 | 48 | 4 | 5a636e952da9b1fd26aa17f7b129054f2da322b5 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 5.18e-05 | 190 | 48 | 4 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-05 | 190 | 48 | 4 | 9cd147a174017ebda23cc47b6d4552d898acd092 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.29e-05 | 191 | 48 | 4 | 509230f50568e5a8ecf08edc4d58f9e2aa96efe9 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.29e-05 | 191 | 48 | 4 | 5c4e4e9de14edfae072a2a2882220a31bebf51b2 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.29e-05 | 191 | 48 | 4 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.29e-05 | 191 | 48 | 4 | 6609d85fd2577633dcc067507304a6f9e5865ca3 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.29e-05 | 191 | 48 | 4 | 0b3dbbc35d9970d3c749aef16dda59886b960e3d | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.29e-05 | 191 | 48 | 4 | 80484d39f34703a33b9bac09826b7a526e883cab | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.29e-05 | 191 | 48 | 4 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.40e-05 | 192 | 48 | 4 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.40e-05 | 192 | 48 | 4 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 192 | 48 | 4 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.40e-05 | 192 | 48 | 4 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.40e-05 | 192 | 48 | 4 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 5.40e-05 | 192 | 48 | 4 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 192 | 48 | 4 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|World / Lineage and Cell class | 5.40e-05 | 192 | 48 | 4 | 0703b8ec6960ff975ee5a2737054db67cab016b5 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 192 | 48 | 4 | 5876ff75e273a48e7ad8236423fb41e4ae4c0a91 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.51e-05 | 193 | 48 | 4 | e27885a9e1a2a3e165c5366d4cfcda05c5454483 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.51e-05 | 193 | 48 | 4 | 5e46a9f65e85aca78f825fdef88a95b97eec8743 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 5.62e-05 | 194 | 48 | 4 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.62e-05 | 194 | 48 | 4 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 195 | 48 | 4 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 5.73e-05 | 195 | 48 | 4 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 195 | 48 | 4 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 195 | 48 | 4 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | Secretory|World / shred by cell class for bronchial biopsy | 5.73e-05 | 195 | 48 | 4 | 52f8281fe0df67cec3faa780a23ed6343ed5a6ba | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-05 | 196 | 48 | 4 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 5.85e-05 | 196 | 48 | 4 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-05 | 196 | 48 | 4 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | critical-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.85e-05 | 196 | 48 | 4 | dbf14f5851c2b779a8b35e820c4584ea9096e49d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.85e-05 | 196 | 48 | 4 | ed818de15f84f7f28bd06fd69d7876710da232a0 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.85e-05 | 196 | 48 | 4 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.85e-05 | 196 | 48 | 4 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 5.85e-05 | 196 | 48 | 4 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocye.Tnr.Cspg5_(Cspg5)|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.93e-05 | 70 | 48 | 3 | c6d3f8cd3f79e2beb826b07a6b9f3ab35d4f23ea | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocye.Tnr.Cspg5_(Cspg5)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.93e-05 | 70 | 48 | 3 | 823921f8bf585d45f24f627b2b77b228898eb85a | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P3-Tnr|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.93e-05 | 70 | 48 | 3 | d2be16550c572ba77261c978648e61dba3eab6bd | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P3|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.93e-05 | 70 | 48 | 3 | 52bde49a05f2387fe3e4357422e155bee2e86ae6 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.97e-05 | 197 | 48 | 4 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 5.97e-05 | 197 | 48 | 4 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | COPD-Stromal|COPD / Disease state, Lineage and Cell class | 5.97e-05 | 197 | 48 | 4 | d5390d86acaa8c39f1da893e8d2271f9ed2951d7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.97e-05 | 197 | 48 | 4 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 5.97e-05 | 197 | 48 | 4 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.97e-05 | 197 | 48 | 4 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | PSB-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.08e-05 | 198 | 48 | 4 | e4cbe4032dba0da3fd46817ea9ad86ba9217f747 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 6.08e-05 | 198 | 48 | 4 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.08e-05 | 198 | 48 | 4 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.08e-05 | 198 | 48 | 4 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | COPD-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 6.08e-05 | 198 | 48 | 4 | 2f13c0b3372af53d1bd85f9546f315c878580a71 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.08e-05 | 198 | 48 | 4 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.08e-05 | 198 | 48 | 4 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.20e-05 | 199 | 48 | 4 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 6.20e-05 | 199 | 48 | 4 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.33e-05 | 200 | 48 | 4 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.33e-05 | 200 | 48 | 4 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.33e-05 | 200 | 48 | 4 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_adventitial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.33e-05 | 200 | 48 | 4 | fc3c4778841c4b8bac0afb458352614b2c460617 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.33e-05 | 200 | 48 | 4 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasmablast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.58e-05 | 76 | 48 | 3 | df1c29cf88b1957e210058e172683f78a1eea2bd | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Tmsb4x_(Tmsb4x)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.10e-04 | 86 | 48 | 3 | db67c05c876a5649371c0dc6c941cc371bc2feb8 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Tmsb4x_(Tmsb4x)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.10e-04 | 86 | 48 | 3 | 2778446e035c5585bce28ed0ef93b87b6ad90c6e | |
| ToppCell | TCGA-Liver-Recurrent_Tumor|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.38e-04 | 93 | 48 | 3 | 16ee6302c55f9ba8fbcc1ad3c47196ce94bbc328 | |
| ToppCell | TCGA-Liver-Recurrent_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.38e-04 | 93 | 48 | 3 | f05700cf25dc0620fb0e05ee3dd4ff7582cfbe95 | |
| ToppCell | TCGA-Liver-Recurrent_Tumor-Hepatocellular_Carcinoma|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.38e-04 | 93 | 48 | 3 | 05ab6ae8f4d05c4a3fc1a13821bf228d18d4d2c2 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.62e-04 | 129 | 48 | 3 | 13cd10ffdd8f1ef7721884e9efd2cf25f170f414 | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Fos_(Microglia)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.52e-04 | 149 | 48 | 3 | 406a5ccfedbf43543f0346ff7ef3ce1d15c38f29 | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.52e-04 | 149 | 48 | 3 | 34a3075af794052763fc7c4135f3031f89da5caa | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.52e-04 | 149 | 48 | 3 | be698ecce34ddbdf57d08082b71268934675e74e | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Fos_(Microglia)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.52e-04 | 149 | 48 | 3 | 183c77cc8f23b8406e7241a066cb684470002a3b | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.63e-04 | 150 | 48 | 3 | 4bdcdce40f54580c7a4e1416b468e657ba8874fc | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.74e-04 | 151 | 48 | 3 | 535872e231ac0ee7b4fc4d02a260752cbbf50a2b | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-9|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.74e-04 | 151 | 48 | 3 | 2314c004434aed9b7fa1ad01c61c43e5ed4a18ce | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.08e-04 | 154 | 48 | 3 | dd3d34f065820e706515a13619f19a5b12734c8e | |
| Disease | Age-related macular degeneration | 2.66e-06 | 18 | 45 | 3 | cv:C0242383 | |
| Disease | cysteine and glycine-rich protein 2 measurement | 6.82e-06 | 3 | 45 | 2 | EFO_0802444 | |
| Disease | complement C3D fragment measurement | 6.82e-06 | 3 | 45 | 2 | EFO_0020277 | |
| Disease | macular degeneration (is_implicated_in) | 9.45e-06 | 27 | 45 | 3 | DOID:4448 (is_implicated_in) | |
| Disease | Age related macular degeneration | 1.31e-05 | 30 | 45 | 3 | C0242383 | |
| Disease | sorting nexin-7 measurement | 1.36e-05 | 4 | 45 | 2 | EFO_0803094 | |
| Disease | protein delta homolog 1 measurement | 2.27e-05 | 5 | 45 | 2 | EFO_0801938 | |
| Disease | interleukin-10 receptor subunit beta measurement | 2.27e-05 | 5 | 45 | 2 | EFO_0020489 | |
| Disease | thymidine kinase, cytosolic measurement | 3.40e-05 | 6 | 45 | 2 | EFO_0020773 | |
| Disease | NKG2-E type II integral membrane protein measurement | 3.40e-05 | 6 | 45 | 2 | EFO_0801842 | |
| Disease | aurora kinase B measurement | 3.40e-05 | 6 | 45 | 2 | EFO_0020169 | |
| Disease | transcription factor AP-1 measurement | 3.40e-05 | 6 | 45 | 2 | EFO_0021909 | |
| Disease | CCAAT/enhancer-binding protein beta measurement | 3.40e-05 | 6 | 45 | 2 | EFO_0021905 | |
| Disease | DNA-binding protein SATB2 measurement | 3.40e-05 | 6 | 45 | 2 | EFO_0802484 | |
| Disease | mast/stem cell growth factor receptor kit measurement | 4.75e-05 | 7 | 45 | 2 | EFO_0020554 | |
| Disease | Glomerulonephritis, Membranoproliferative | 4.75e-05 | 7 | 45 | 2 | C0017662 | |
| Disease | sialic acid-binding Ig-like lectin 6 measurement | 6.33e-05 | 8 | 45 | 2 | EFO_0008285 | |
| Disease | anterior uveitis (is_implicated_in) | 6.33e-05 | 8 | 45 | 2 | DOID:1407 (is_implicated_in) | |
| Disease | PH and SEC7 domain-containing protein 1 measurement | 6.33e-05 | 8 | 45 | 2 | EFO_0803302 | |
| Disease | atypical hemolytic-uremic syndrome (is_implicated_in) | 6.33e-05 | 8 | 45 | 2 | DOID:0080301 (is_implicated_in) | |
| Disease | complement C1q and tumor necrosis factor-related protein 9A measurement | 8.13e-05 | 9 | 45 | 2 | EFO_0803293 | |
| Disease | C3 glomerulopathy | 8.13e-05 | 9 | 45 | 2 | C4087273 | |
| Disease | Atypical hemolytic-uremic syndrome | 8.13e-05 | 9 | 45 | 2 | cv:C2931788 | |
| Disease | Hemolytic-uremic syndrome | 8.13e-05 | 9 | 45 | 2 | cv:C0019061 | |
| Disease | complement factor B measurement | 8.13e-05 | 9 | 45 | 2 | EFO_0008096 | |
| Disease | tumor necrosis factor ligand superfamily member 14 measurement | 8.13e-05 | 9 | 45 | 2 | EFO_0010613 | |
| Disease | Fuchs endothelial corneal dystrophy | 1.02e-04 | 10 | 45 | 2 | Orphanet_98974 | |
| Disease | Atypical Hemolytic Uremic Syndrome | 1.02e-04 | 10 | 45 | 2 | C2931788 | |
| Disease | interleukin-37 measurement | 1.02e-04 | 10 | 45 | 2 | EFO_0020506 | |
| Disease | PR domain zinc finger protein 1 measurement | 1.24e-04 | 11 | 45 | 2 | EFO_0801904 | |
| Disease | UDP-glucuronic acid decarboxylase 1 measurement | 1.24e-04 | 11 | 45 | 2 | EFO_0803221 | |
| Disease | oncostatin-M measurement | 1.49e-04 | 12 | 45 | 2 | EFO_0010792 | |
| Disease | wet macular degeneration | 2.05e-04 | 14 | 45 | 2 | EFO_0004683 | |
| Disease | C-C motif chemokine 19 measurement | 2.05e-04 | 14 | 45 | 2 | EFO_0008047 | |
| Disease | atrophic macular degeneration | 6.67e-04 | 25 | 45 | 2 | EFO_1001492 | |
| Disease | myeloperoxidase measurement | 7.22e-04 | 26 | 45 | 2 | EFO_0005243 | |
| Disease | retinal degeneration (biomarker_via_orthology) | 8.38e-04 | 28 | 45 | 2 | DOID:8466 (biomarker_via_orthology) | |
| Disease | D dimer measurement | 9.63e-04 | 30 | 45 | 2 | EFO_0004507 | |
| Disease | rheumatic heart disease | 1.17e-03 | 33 | 45 | 2 | EFO_1001161 | |
| Disease | Complement deficiency disease | 1.17e-03 | 33 | 45 | 2 | C0272242 | |
| Disease | obese body mass index status | 1.17e-03 | 33 | 45 | 2 | EFO_0007041 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GDPYWAYSGAYGPEH | 56 | P23470 | |
| YGDPEVHPQSEDYWG | 206 | Q8NBZ7 | |
| PAAYGAPLREDWNGY | 66 | Q99626 | |
| PWYLPPDFPYYHDEG | 1266 | P78357 | |
| PDFPYYHDEGWVAIL | 1271 | P78357 | |
| FVNYPPGDEAHWPQY | 156 | P41238 | |
| PFGEYPALTLHPWIY | 1396 | P78363 | |
| TPHGPDLYGTEPWYF | 291 | Q9H6U8 | |
| ELEHGWAQLSSPPYY | 696 | P08603 | |
| EGYYHPLGGGREVWF | 176 | Q9HCK5 | |
| SGSPPHYFYWSREDG | 1701 | P98160 | |
| PHDFENGEYWPRSPY | 106 | P00751 | |
| AAYLYPPKHWRYGEA | 86 | Q96G91 | |
| DPPCYEFLWGPRAYA | 351 | Q8N7X4 | |
| NPPEYEFLWGLRSYH | 626 | Q9Y5V3 | |
| AYGHFGRDSFPWEVP | 376 | P31153 | |
| SYHDYDEPPEEGLWP | 3616 | Q9UPA5 | |
| RGSPPILYWFYHEDV | 591 | Q96RD9 | |
| LGWFAHPIFRNGDYP | 1151 | P09848 | |
| IFYYLNHDWPFGPGL | 76 | Q9BXC1 | |
| ELFLGWPLYPGALEY | 391 | Q9H422 | |
| LPLLVYYYARGDHWP | 86 | P41231 | |
| APDLFWGTYRPHVYF | 91 | Q13724 | |
| PLLGWGHYDYEPLGT | 146 | P47804 | |
| WEFVDPYPVNKYGHE | 406 | Q96M94 | |
| ALRGSPPILYWFYHE | 231 | Q96LA6 | |
| PPILYWFYHEDITLG | 236 | Q96LA6 | |
| KLHWERAEPPGPYFY | 3006 | P12111 | |
| PKGLWGYYLYPDCHN | 211 | Q2M3T9 | |
| GLEWFPELYPGYLGL | 461 | Q9BSJ5 | |
| NLEWLYGCPPPYHTF | 491 | P00395 | |
| AYWAGGLHLYTPLPF | 366 | Q9Y512 | |
| PPALLEEFYAGGWHY | 306 | O43304 | |
| QGHAYPVWDLDISPY | 381 | O75529 | |
| PGDNVFGYDWSHDYP | 31 | Q9P1P4 | |
| ASSPLYPAFWLYGLH | 406 | Q8IUD6 | |
| YPAFWLYGLHPGNYL | 411 | Q8IUD6 | |
| AGARWREALPGPHYY | 526 | Q92673 | |
| YLYGLPDDISHGYGW | 236 | H3BS89 | |
| FYPWANHILLPSLYG | 1331 | Q7Z443 | |
| YPQDGWTDSDPVHGY | 51 | Q9NYZ4 | |
| YTWELSPHLYFLAPG | 891 | O94911 | |
| FPAPPAHWFYGHKEF | 46 | Q86W10 | |
| LGAPYSEAWGYFHLA | 41 | Q96IU2 | |
| EAWYPPGHGDIYASF | 216 | Q16851 | |
| YALYAARDWKPFHGG | 1066 | Q9H9J4 | |
| CFYKHEYPEGWGDEP | 416 | Q13064 | |
| PHYGAYIFPDWANAL | 546 | Q01959 | |
| PGYQHWALYLGDGYV | 26 | Q9HDD0 | |
| PGDWHQPVSGVDYYE | 76 | Q96JE7 | |
| DPAGSYHPVGERWYT | 1871 | Q9Y493 | |
| VPFHWHGPGYSEVIY | 176 | Q96S16 | |
| PHPFGLTLYGERIYW | 946 | O75096 |